Hospira Reports Second-Quarter 20...( -- Increases 2008 Net Sales Projec...),Health

-- Increases 2008 Net Sales Projections; Affirms Top End of Adjusted*

Earnings Guidance --

LAKE FOREST, Ill., Aug. 6 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today reported results for the second quarter of 2008.

-- Net sales increased 3.7 percent to $901.6 million during the second

quarter of 2008, compared to $869.3 million during the second quarter

of 2007.

-- Adjusted* diluted earnings per share during the second quarter of 2008

were $0.57 compared to $0.49 during the second quarter last year. GAAP

second-quarter 2008 diluted earnings per share were $0.43 versus $0.20

for the same period last year. (Adjusted* measures exclude certain

specified items as described later in this press release and attached

schedules.)

"We made substantial progress advancing our business during the second quarter and remain on track to deliver another good year," said Christopher B. Begley, chairman and chief executive officer. "The market-share gains we are capturing in both Specialty Injectable Pharmaceuticals and Medication Management Systems point to the value of our focus on strategic execution. With our solid year-to-date results and expectations for the remainder of the year, we are increasing our full-year sales guidance and narrowing our adjusted* EPS guidance to the top end of our projected range."

Second-quarter Financial Highlights

The following table summarizes selected financial results for the quarters ended June 30:

In $ millions GAAP Adjusted*

Three
'/>"/>